Ophthalmic nepafenac is used to treat eye pain, redness, and swelling in patients who are recovering from cataract surgery (procedure to treat clouding of the lens in the eye). Nepafenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the production of certain natural substances that cause pain and swelling.
Ophthalmic nepafenac comes as a suspension (liquid) to instill in the eyes. It is usually instilled three times a day beginning one day before cataract surgery, on the day of the surgery, and for 14 days after the surgery. Use nepafenac eye drops at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use nepafenac eye drops exactly as directed. Do not use more or less of them or use them more often than prescribed by your doctor.
To use the eye drops, follow these steps: Wash your hands thoroughly with soap and water.Check the dropper tip to make sure that it is not chipped or cracked.Avoid touching the dropper tip against your eye or anything else; eye drops and droppers must be kept clean.While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.Brace the remaining fingers of that hand against your face.While looking up, gently squeeze the dropper so that a single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.Close your eye for 2 to 3 minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.Place a finger on the tear duct and apply gentle pressure.Wipe any excess liquid from your face with a tissue.If you are to use more than one drop in the same eye, wait at least 5 minutes before instilling the next drop.Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.Wash your hands to remove any medication.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Before using nepafenac eye drops, tell your doctor and pharmacist if you are allergic to nepafenac; aspirin or other NSAIDs such as diclofenac (Voltaren), ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn), or tolmetin (Tolectin); any other medications, or any of the ingredients in nepafenac eye drops. Ask your pharmacist for a list of the ingredients.tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin); aspirin and other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); and corticosteroid eye drops such as dexamethasone (Maxidex), fluorometholone (FML), hydrocortisone (in Cortisporin), loteprednol (Alrex, Lotemax), medrysone (HMS), prednisolone (Pred Mild), and rimexolone (Vexol). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.if you are using another topical eye medication, instill it at least 5 minutes before or after you instill nepafenac eye drops.tell your doctor if you have or have ever had diabetes, rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), dry eye disease or any eye problem other than cataracts, or any condition that causes you to bleed easily.tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, you plan to become pregnant, or you are breast-feeding. If you become pregnant while using nepafenac eye drops, call your doctor.if you wear contact lenses, remove them before you use nepafenac eye drops.
Unless your doctor tells you otherwise, continue your normal diet.
Instill the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not instill extra eye drops to make up for a missed dose.
Nepafenac eye drops may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: headacherunny nosepain or pressure in the facenauseavomitingdry, itchy, or sticky eyes
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately: red or bloody eyeseye painfeeling that something is in the eyesensitivity to lightblurred or decreased visionseeing specks or spotsteary eyeseye discharge or crusting
Nepafenac eye drops may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at Web Site] or by phone [1-800-332-1088].
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
Keep all appointments with your doctor
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: April 15, 2011.